Quantcast

Latest Over-the-counter drug Stories

2014-02-11 23:03:20

This technical market research report from BCC Research provides an overview of the global market for OTC drugs and dietary supplements. It covers developed and emerging markets in order to help readers understand the current state of the OTC medicines and dietary supplements market and the key markets for its future development. (PRWEB) February 11, 2014 According to a new technical market research report Over-the-Counter Drugs (OTC) and Dietary Supplements: Global Markets, from BCC...

2014-02-11 16:26:04

WHIPPANY, N.J., Feb. 11, 2014 /PRNewswire/ -- Bayer HealthCare today issued the following press statement from Dr. Irene Laurora, Vice President, US Medical Affairs, following a joint meeting of the Arthritis Advisory Committee (AAC) and Drug Safety Committee and Risk Management Advisory Committee (DSaRM) on February 10-11, 2014. The joint Advisory Committee panel reviewed the data and analyses published since the last non-steroidal anti-inflammatory drug (NSAID) panel review in 2005...

2014-02-10 08:25:15

BURLINGAME, Calif., Feb. 10, 2014 /PRNewswire/ -- First Aid Shot Therapy® (F.A.S.T.), a consumer healthcare company focused on over-the-counter (OTC) medicine in liquid 'shot' (40ml / 1.35oz.) form, announced today that it has completed a Series B financing round. Sofinnova Ventures and Redmile Group co-led the round with additional support from investors including Sofinnova HealthQuest, Clearwell Group and Mark Rampolla, Founder and former CEO of ZICO Beverages, maker of ZICO Pure...

2014-02-04 12:28:20

First and only medicine in its class approved for over-the-counter use that provides 24 hour relief of the full range of nasal allergy symptoms including nasal congestion BRIDGEWATER, N.J., Feb. 4, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and its U.S. consumer healthcare division Chattem announced today that Nasacort(®) Allergy 24HR Nasal Spray is now available over-the-counter (OTC) in the U.S. to relieve the full range of seasonal and year-round nasal allergy...

2014-01-30 16:26:09

When a one-size-fits-all prescription isn't the best remedy, patients can count on OuRX Pharmacy to create customized medications to fit their unique needs LOS ANGELES, Jan. 30, 2014 /PRNewswire/ -- Santa Monica compounding pharmacy, OuRX Pharmacy, Inc. is one of few independently-run stores of its kind in the Los Angeles area. The Santa Monica pharmacy dispenses specialized medications that can't be found at mass-producing pharmaceutical companies. Operated by Dr. Homayoon Khorsandi, OuRX...

2014-01-29 12:27:27

DUBLIN, Jan. 29, 2014 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on March 18, 2014 to shareholders of record on February 28, 2014. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO) From its beginnings as a packager of generic home remedies in 1887, Perrigo Company plc, headquartered in Ireland, has grown to become a leading global healthcare supplier....

2014-01-24 08:23:52

DUBLIN, Jan. 24, 2014 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin® Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013. (Logo:...

2014-01-23 12:29:07

DUBLIN, Jan. 23, 2014 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter fiscal year 2014 on Thursday, February 6, 2014 at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman, President and Chief Executive Officer. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO) The conference call will be available...

2014-01-16 16:24:12

WASHINGTON, Jan. 16, 2014 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) today released the following statement after Tennessee Governor Bill Haslam unveiled new legislation that would limit law-abiding consumers' access to popular nonprescription cold and allergy medicines containing pseudoephedrine (PSE). The governor's bill would reduce the amount of PSE-based medicines consumers can buy to 2.4 grams for a 30-day period, or 28.8 grams per year--a reduction...

2014-01-15 08:29:16

NEW DELHI, January 15, 2014 /PRNewswire/ -- - Cold and Cough remedies has conventionally remained the leading segment of the industry with a value share of 24.9% of the total sales as of 2012 - The vitamins and mineral supplements sales value have increased predominantly over the years from USD 873.9 million in 2006 to USD 1,091.9 million in 2012 - Slovakia has emerged as the fastest growing market for OTC drugs in the region...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.